Icon
+91 94997 68112
Login Register

LEVOTHYROXINE SODIUM (nda202231)- (100MCG/VIAL,200MCG/VIAL,500MCG/VIAL)

LEVOTHYROXINE SODIUM FRESENIUS KABI USA
100MCG/VIAL,200MCG/VIAL,500MCG/VIAL
Yes Yes
2032-Oct-03 Expired
None None
None No
Levothyroxine Sodium is an L-thyroxine product. Levothyroxine (T4) Sodium for Injection is indicated for the treatment of myxedema coma.
3 0 2
Total Other Developers None
Drugs with Suitability No
100MCG/VIAL ** ** - - -
200MCG/VIAL ** ** - - -
500MCG/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 1
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ******** ******* ************, *.*.*. *********** ***** ***** **., *****, **** (**) *****, ****** ****** (***) ***
****** **** ****** *** ***** ****** ******* *********** ****** **. *** - ***, *** & ***, **** ************* ***** *****, *. *. *****, ******** ****, ******** - ************* ******, ******* - ********** ********, *********, ********* ******, ***** (***) ***

Download GenUS Drug Report

Download GenUS Detailed Report

To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.